Cancer Control Journal Vol 4, No 2
CME Pretest

In this issue, the topic of cancer prevention is addressed. First, answer the pretest questions below. After reading the articles, proceed with answering the CME posttest questions.

This Journal provides 4 hours of Category I Continuing Medical Education

Complimentary CME Credits

Physicians can earn up to 4 credit hours of Category I for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions on the posttest at the end of this issue. Complete instructions are given on the posttest pages. Every successfully answered 10 questions will earn 1 credit hour. CME is presented by an unrestricted educational grant from Bristol-Myers Oncology Division.

Educational Objectives

After reading this issue, clinicians will be expected to:

• be familiar with genetic, biochemical, and histologic precursors of cancer;
  
• understand the epidemiology of carcinogenesis and know the results of cancer prevention intervention studies; and
  
• implement effective treatment of painful bone metasases.

This program was planned in accordance with ACCME Essentials.
Release Date: March 15, 1997 Expiration Date: March 15, 1998

Pretest

1. What degree of increase in risk for breast cancer is anticipated for women who have a daily alcohol intake equivalent to two drinks?

a. 0%

b. 25%

c. 40%

d. 80%

2. The current active intergroup chemoprevention trial for patients "cured" of stages 1 and 2 head and neck squamous cancer compares placebo with three years of:

a. 4-hydroxyphenyl retinamide, 200 mg/d

b. vitamin A, 200,000 IU/wk

c. 13-cis-retinoic acid, 30 mg/d

d. beta-carotene, 30 mg/d

3. The World Health Organization guidelines suggest what intervention for patients with mild to moderate pain?

a. NSAIDs

b. opioids

c. NSAIDs plus opioids

d. NSAIDs plus anxiolytics